Controlled (balanced) diabetes-Uncontrolled Posts on Medivizor
Navigation Menu

Controlled (balanced) diabetes-Uncontrolled Posts on Medivizor

Effectiveness and safety of tirzepatide compared to insulin degludec in patients with type 2 diabetes.

Effectiveness and safety of tirzepatide compared to insulin degludec in patients with type 2 diabetes.

Posted by on Oct 31, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of tirzepatide to insulin degludec (Tresiba) in patients with uncontrolled type 2 diabetes (T2D). The data showed that tirzepatide produced better blood glucose control and body weight improvements with reduced risk of hypoglycemia, compared to degludec in these patients. Some...

Read More

Is weight loss due to dulaglutide treatment dose-dependent in patients with type 2 diabetes?

Is weight loss due to dulaglutide treatment dose-dependent in patients with type 2 diabetes?

Posted by on Aug 22, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effect of administering 1.5 mg, 3 mg, and 4.5 mg of dulaglutide (Trulicity) on overall bodyweight reduction in patients with type 2 diabetes (T2D). The authors concluded that higher doses of dulaglutide caused more weight loss in these patients. Some background Abnormal or excessive levels of fat in the...

Read More

Is dapagliflozin add-on a good treatment option for patients with type 2 diabetes on insulin?

Is dapagliflozin add-on a good treatment option for patients with type 2 diabetes on insulin?

Posted by on Jun 13, 2021 in Diabetes mellitus | 0 comments

In a nutshell In this study, the authors evaluated the effectiveness of adding dapagliflozin (Farxiga) to insulin therapy in patients with uncontrolled type 2 diabetes (T2D). The study showed that compared to increasing insulin doses, dapagliflozin improved glucose control while reducing weight and hypoglycemia (dangerously low blood...

Read More

Which type of insulin is best for avoiding hypoglycemia in patients with high risk type 2 diabetes?

Which type of insulin is best for avoiding hypoglycemia in patients with high risk type 2 diabetes?

Posted by on Apr 30, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study compared the risk of hypoglycemia (dangerously low blood glucose levels) for insulin glargine 300 U/ml (Gla-300; Toujeo) and standard-of-care basal insulin (SOC-BI) at patients with type 2 diabetes (T2D) with risk factors for hypoglycemia. It found that Gla-300 was associated with a lower risk of hypoglycemia than...

Read More

Is omarigliptin safe and effective in insulin-treated patients with uncontrolled type 2 diabetes?

Is omarigliptin safe and effective in insulin-treated patients with uncontrolled type 2 diabetes?

Posted by on Feb 28, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the use of omarigliptin (Marizev) in insulin-treated patients with uncontrolled type 2 diabetes (T2D). It found that omarigliptin was well-tolerated and improved blood glucose control.  Some background Type 2 diabetes (T2D) is usually treated initially with diet, exercise, and...

Read More

Which diabetic drug is safer for older patients with type 2 diabetes, linagliptin or glimepiride?

Which diabetic drug is safer for older patients with type 2 diabetes, linagliptin or glimepiride?

Posted by on Dec 13, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared the safety of two medications, linagliptin (Trajenta) and glimepiride (Amaryl). It found that the medications had the same risk of heart attack, stroke, or heart-related death, while linagliptin was associated with a lower risk of hypoglycemia (dangerously low blood glucose level). Some background There...

Read More

Adding exenatide to insulin treatment in patients with type 2 diabetes

Adding exenatide to insulin treatment in patients with type 2 diabetes

Posted by on Nov 8, 2020 in Diabetes mellitus | 0 comments

In a nutshell This controlled trial looked at adding exenatide (Byetta) to intensive insulin treatment for patients with type 2 diabetes (T2D) who still had high blood sugar. It found that the exenatide improved blood sugar control and reduced body weight in these patients. Some background T2D is a metabolic condition in which the body does not...

Read More

How safe and effective is non-insulin drug dapagliflozin long-term for patients with uncontrolled type 1 diabetes?

How safe and effective is non-insulin drug dapagliflozin long-term for patients with uncontrolled type 1 diabetes?

Posted by on May 17, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared two doses of dapagliflozin (Farxiga) to a placebo to determine how effective and safe they were long-term for patients with uncontrolled type 1 diabetes (T1D). The results showed that both doses were able to reduce blood glucose levels and body weight but increased the risk of ketoacidosis. Some background...

Read More

How effective and safe is non-insulin drug evogliptin for patients with type 2 diabetes?

Posted by on May 10, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of evogliptin (Suganon) to another non-insulin drug, linagliptin (Tradjenta), in patients with type 2 diabetes (T2D). The results showed that evogliptin was as safe and effective at reducing patients’ blood glucose levels as linagliptin. Some background Several treatment options...

Read More